Trial intelligence / Profile preview

Azelastine/Fluticasone vs High-Dose Fluticasone in Persistent Allergic Rhinitis

NCT00845598Phase 4Withdrawn

Sponsor
University of Dundee
Start
Aug 2010
Primary completion
Aug 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of azelastine + fluticasone in allergic rhinitis (AR), sponsored by University of Dundee. Planned start Aug 2010; status: withdrawn.

02

Drugs

azelastine + fluticasone
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NCT00845598.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00845598.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call